These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 36869589)
1. CTLA-4 blockade induces tumor pyroptosis via CD8 Wang S; Wu ZZ; Zhu SW; Wan SC; Zhang MJ; Zhang BX; Yang QC; Xiao Y; Li H; Mao L; Wang ZY; Gutkind JS; Sun ZJ Mol Ther; 2023 Jul; 31(7):2154-2168. PubMed ID: 36869589 [TBL] [Abstract][Full Text] [Related]
2. CTLA4 DNA methylation is associated with CTLA-4 expression and predicts response to immunotherapy in head and neck squamous cell carcinoma. Hoffmann F; Franzen A; de Vos L; Wuest L; Kulcsár Z; Fietz S; Maas AP; Hollick S; Diop MY; Gabrielpillai J; Vogt T; Kuster P; Zarbl R; Dietrich J; Kristiansen G; Brossart P; Landsberg J; Strieth S; Dietrich D Clin Epigenetics; 2023 Jul; 15(1):112. PubMed ID: 37415208 [TBL] [Abstract][Full Text] [Related]
3. Blockade of adenosine A2A receptor enhances CD8 Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285 [TBL] [Abstract][Full Text] [Related]
4. SP140 inhibits STAT1 signaling, induces IFN-γ in tumor-associated macrophages, and is a predictive biomarker of immunotherapy response. Tanagala KKK; Morin-Baxter J; Carvajal R; Cheema M; Dubey S; Nakagawa H; Yoon A; Cheng YL; Taylor A; Nickerson J; Mintz A; Momen-Heravi F J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36600652 [TBL] [Abstract][Full Text] [Related]
5. Differential contribution of three immune checkpoint (VISTA, CTLA-4, PD-1) pathways to antitumor responses against squamous cell carcinoma. Kondo Y; Ohno T; Nishii N; Harada K; Yagita H; Azuma M Oral Oncol; 2016 Jun; 57():54-60. PubMed ID: 27208845 [TBL] [Abstract][Full Text] [Related]
6. Tertiary Lymphoid Structure Raises Survival and Immunotherapy in HPV Li H; Zhu SW; Zhou JJ; Chen DR; Liu J; Wu ZZ; Wang WY; Zhang MJ; Sun ZJ J Dent Res; 2023 Jun; 102(6):678-688. PubMed ID: 36883630 [TBL] [Abstract][Full Text] [Related]
7. Improved antitumor immunity of chemotherapy in OSCC treatment by Gasdermin-E mediated pyroptosis. Zi M; Xingyu C; Yang C; Xiaodong S; Shixian L; Shicheng W Apoptosis; 2023 Apr; 28(3-4):348-361. PubMed ID: 36370260 [TBL] [Abstract][Full Text] [Related]
8. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma. Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843 [TBL] [Abstract][Full Text] [Related]
9. Specific blockade CD73 alters the "exhausted" phenotype of T cells in head and neck squamous cell carcinoma. Deng WW; Li YC; Ma SR; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ Int J Cancer; 2018 Sep; 143(6):1494-1504. PubMed ID: 29663369 [TBL] [Abstract][Full Text] [Related]
10. The effect of Curcumin on multi-level immune checkpoint blockade and T cell dysfunction in head and neck cancer. Liu L; Lim MA; Jung SN; Oh C; Won HR; Jin YL; Piao Y; Kim HJ; Chang JW; Koo BS Phytomedicine; 2021 Nov; 92():153758. PubMed ID: 34592487 [TBL] [Abstract][Full Text] [Related]
11. Tumor microenvironmental modification by the current target therapy for head and neck squamous cell carcinoma. Okuyama K; Naruse T; Yanamoto S J Exp Clin Cancer Res; 2023 May; 42(1):114. PubMed ID: 37143088 [TBL] [Abstract][Full Text] [Related]
12. Regulatory and effector T cell subsets in tumor-draining lymph nodes of patients with squamous cell carcinoma of head and neck. Norouzian M; Mehdipour F; Ashraf MJ; Khademi B; Ghaderi A BMC Immunol; 2022 Nov; 23(1):56. PubMed ID: 36376825 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of SRC family kinases facilitates anti-CTLA4 immunotherapy in head and neck squamous cell carcinoma. Yu GT; Mao L; Wu L; Deng WW; Bu LL; Liu JF; Chen L; Yang LL; Wu H; Zhang WF; Sun ZJ Cell Mol Life Sci; 2018 Nov; 75(22):4223-4234. PubMed ID: 29955905 [TBL] [Abstract][Full Text] [Related]
14. Prognostic and chemotherapeutic implications of a novel four-gene pyroptosis model in head and neck squamous cell carcinoma. Yuan P; Jiang S; Wang Q; Wu Y; Jiang Y; Xu H; Jiang L; Luo X PeerJ; 2024; 12():e17296. PubMed ID: 38756442 [TBL] [Abstract][Full Text] [Related]
15. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients. Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X Front Immunol; 2022; 13():1100417. PubMed ID: 36703967 [TBL] [Abstract][Full Text] [Related]
17. A comprehensive profile of TCF1 Wang D; Fang J; Wen S; Li Q; Wang J; Yang L; Dai W; Lu H; Guo J; Shan Z; Xie W; Liu X; Wen L; Shen J; Wang A; Chen Q; Wang Z Int J Oral Sci; 2022 Feb; 14(1):8. PubMed ID: 35153298 [TBL] [Abstract][Full Text] [Related]
18. Immune checkpoint blockade induced shifts in cytokine expression patterns in peripheral blood of head and neck cancer patients are linked to outcome. Röhl L; Wellhausen J; Berszin M; Krücken I; Zebralla V; Pirlich M; Wiegand S; Dietz A; Wald T; Wichmann G Front Immunol; 2023; 14():1237623. PubMed ID: 37849764 [TBL] [Abstract][Full Text] [Related]
19. Checkpoint blockade accelerates a novel switch from an NKT-driven TNFα response toward a T cell driven IFN-γ response within the tumor microenvironment. Aoyama S; Nakagawa R; Nemoto S; Perez-Villarroel P; Mulé JJ; Mailloux AW J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34135102 [TBL] [Abstract][Full Text] [Related]
20. Identification of Immune Subtypes for Predicting the Prognosis of Patients in Head and Neck Squamous Cell Carcinoma. Sun J; Fang G; Zuo Z; Yu X; Xue L; Li C; Li S Technol Cancer Res Treat; 2021; 20():15330338211045823. PubMed ID: 34657509 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]